MedImmune Description

MedImmune was the global biologics research and development arm of AstraZeneca, specializing in the discovery, development, and commercialization of innovative biologic medicines. The company focused on several therapeutic areas, including infectious diseases, oncology, respiratory diseases, cardiovascular conditions, and autoimmune disorders.

Key Areas of Focus:

• Vaccines and Immunotherapies – Developed preventive and therapeutic biologics, including monoclonal antibodies for infectious diseases.
• Respiratory and Inflammation – Focused on treatments for conditions like asthma and chronic obstructive pulmonary disease (COPD).
• Oncology and Rare Diseases – Pioneered advancements in biologics for cancer treatment and rare genetic disorders.
• Autoimmune Disorders – Worked on biologic solutions for diseases like lupus and rheumatoid arthritis.